More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Skipping your dose to over-indulge could leave you “excusing yourself from the table in a hurry,” an expert tells PEOPLE.

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

China’s National Medical Products Administration (NMPA) approved Wegovy in late June. It is intended for individuals with a ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Researchers studied the trends in alcohol use after the COVID-19 pandemic, comparing data from 2018, 2020 and 2022.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...